On September 20 2022, the MSD meeting ‘Real-World Data collection and evidence generation in Belgium: Importance for prevention of infectious diseases’ takes place at hotel Park Inn by Radisson Brussels Airport. This meeting is organized with the support of Flanders Vaccine.
While Real-World Evidence (RWE) has already been used for a long time for post-marketing safety studies, the COVID-19 pandemic has demonstrated the major assets of the use of RWD for vaccine development. RWE addresses questions about vaccine development that may remain unanswered after being studied in a clinical trial. RWD and the evolving analytic techniques to generate RWE have allowed the research and medical communities to boost clinical research.
Exchange around real-world data collection in Belgium and evidence generation from different perspectives is a key tool for policy recommendation.
Real-world-data collection is gaining importance and high-quality disease registries, data collection and exchange of data will play an even greater role in the future to keep Belgium attractive as a hub for vaccine clinical trials. Modelling of infectious diseases is a specialized expertise and it is of major importance to have adequate, top-notch models and techniques to make the right decisions in healthcare. The latest evolutions in this domain will be shared during this meeting.
The intent of this meeting is to have an informal exchange of expertise and experience on the above-mentioned topics which will be beneficial for all parties and provide ideas for future collaborations, research and initiatives.
PROGRAMME
12:15 | Registration & Welcome Lunch
13:15 | Welcome by Valérie Laigle, Market Access Regional Lead Europe, MSD
13:20 | Impact of the COVID-19 pandemic on pediatric infectious diseases (RSV & Varicella) using epidemiologic methods on search engine data
Yao-Hsuan Chen, Director, Vaccine, Health Economic and Decision Sciences, MSD; Frederick Wittke, Executive Director, TA Head European Clinical Development Vaccines, MSD; Ugne Sabale, Director, Outcomes Research, MSD
13:45 | SESSION COVID-19
-
- COVID-19 vaccine surveillance in Belgium: the LINK-VACC project
Joris van Loenhout, Team lead COVID-19 vaccination surveillance, Department of Epidemiology and Public Health, Sciensano - COVIDRIVE: Assessing brand-specific COVID-19 vaccine effectiveness in Europe
Kaatje Bollaert, Head of Data Science, P95 - The evolving burden of COVID-19: the impact of vaccination on illness occurrence and severity
Morgan Marks, Senior Principal Scientist Pharmacoepidemiology, MSD - Discussion & Exchange
- COVID-19 vaccine surveillance in Belgium: the LINK-VACC project
15:00 | Coffee break
15:30 | Data meagreness in modelling infectious diseases & ViralTransM tool to predict the effectiveness of antivirals
Niel Hens, Full Professor of Biostatistics at Hasselt University and the University of Antwerp
16:00 | SESSION HPV
-
- Registry studies to assess impact and vaccine effectiveness of Gardasil and Gardasil 9 in Sweden: experience and limitations
Susanne Hartwig, Senior Principal Scientist Epidemiology, MSD - HPV registries and situation in Belgium
Marc Arbyn, Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano - Discussion & Exchange
- Registry studies to assess impact and vaccine effectiveness of Gardasil and Gardasil 9 in Sweden: experience and limitations
16:45 | Data Analysis and Real World Interrogation Network (DARWIN EU) of the European Medicines Agency (EMA)
Hugues Malonne, Director General Pre-authorisation, FAMHP
17:10 | Closing by An Cloet, External Affairs Director, MSD
17:15 | Networking reception
REGISTRATION
Participation in this meeting is on invitation and registration is required as the number of participants is limited. Are you a Belgian RWD-expert or health-economist and interested to join this meeting, please contact Fran Van Heuverswyn.
PRACTICAL INFORMATION
- VENUE of Meeting: Park Inn by Radisson Brussels Airport. More information about accessing the venue can be found via the website of the hotel.
- ADDRESS: Grensstraat 3, Diegem, Brussels, 1831, Belgium
- PARKING: The underground parking of the hotel is available for free. Access via Culliganlaan 1, 1831 Diegem.
-> Enter the building via the barrier, you will receive a ticket upon entry. Kindly hold the ticket with you as it needs to be validated at the reception desk prior to your departure. Follow the Park Inn signs and park your car at a spot reserved for Park Inn Guests. These are located close to the entrance of the hotel at the end of the parking and spread over 3 floors. The parking is equipped with 4 charching stations for electrical cars, free to use.
Important: The meeting is a NON-CONFIDENTIAL forum for discussion and exchange of scientific information and knowledge. As such, information presented or otherwise disclosed by participants and/or exchanged during discussion at the meeting shall NOT BE CONFIDENTIAL and shall therefore not be subject to any confidentiality obligations.
This event is organises on behalf of MSD.
For more information, contact Fran Van Heuverswyn, Flanders Vaccine’s Project Manager.
